What Are Pyrimethamine & Sulfadiazine Side Effects?
At a Glance
The most common side effect of pyrimethamine and sulfadiazine in babies is a drop in blood cell counts, which can weaken the immune system. Strict daily use of prescription folinic acid and frequent blood tests are absolutely required to keep your baby safe during their year-long treatment.
In this answer
5 sections
Managing a 12-month medication schedule for an infant is exhausting and stressful, but sticking to this routine is the best way to protect your baby’s future health. Treating congenital toxoplasmosis requires a rigorous course of three medications: pyrimethamine, sulfadiazine, and folinic acid (leucovorin) [1][2]. While this triple therapy is highly effective at protecting your baby’s developing brain and vision [3], it can cause significant side effects.
The most common and important side effect to watch for is bone marrow suppression—a drop in blood cell counts that can lead to a weakened immune system, anemia, or bleeding issues [4][5]. Other potential side effects include severe skin rashes and kidney stress [6][7]. Because many of these side effects happen internally before they cause physical symptoms, keeping a strict schedule of routine blood draws is an absolute necessity throughout the entire first year.
Bone Marrow Suppression
Pyrimethamine works by targeting folate, a nutrient the toxoplasmosis parasite needs to survive. However, it can also interfere with your baby’s own ability to make healthy blood cells [5][8]. This can lead to drops in three main types of blood cells, which occur in up to 44% of infants on this therapy [4]:
- Neutropenia (Low White Blood Cells): This is the most common hematologic side effect, affecting up to 31% of infants [4][9]. White blood cells fight off infections, so neutropenia makes your baby more vulnerable to catching illnesses. WARNING: If your baby develops a fever while on this medication, treat it as a medical emergency. Do not try to manage it at home. Contact your doctor or go to the emergency room immediately.
- Anemia (Low Red Blood Cells): Red blood cells carry oxygen throughout the body. A drop can make your baby appear unusually pale, tired, or irritable [4].
- Thrombocytopenia (Low Platelets): Platelets help the blood clot. Low levels can cause unexplained bruising or tiny red or purple spots on the skin (petechiae) [4].
To protect the bone marrow, your baby will be prescribed folinic acid (leucovorin). This is a specialized, prescription-only form of vitamin B9 that protects your baby’s blood cell production without reducing the medication’s ability to fight the parasite [1][10]. Note: You cannot substitute this with over-the-counter folic acid supplements. Standard folic acid does not adequately protect the bone marrow and can actually stop the parasite medication from working. If your baby’s blood counts drop, your doctor can usually manage the problem by simply increasing the dose of folinic acid or briefly pausing the treatment [4].
Skin Rashes and Allergic Reactions
Sulfadiazine is a “sulfa” drug. While rare, some babies can have severe allergic reactions to sulfa medications [11]. It is crucial to monitor your baby’s skin daily. If you notice any new rash—especially if it involves peeling skin, blisters, or sores inside the mouth—you should contact your doctor immediately. These could be early signs of serious, potentially life-threatening hypersensitivity reactions like Stevens-Johnson Syndrome (SJS) [12][13][14]. Tip: Take a clear photo of any new rash as soon as you notice it so your doctor can see if it is spreading.
Kidney Health and Hydration
Sulfadiazine can also affect the kidneys. In some cases, the medication can form microscopic crystals in the urine (crystalluria), which can cause kidney irritation or damage [6][5]. The best way to prevent this is to ensure your baby is well-hydrated. Discuss wet diaper targets with your pediatrician—as a general baseline, infants should produce at least 6 heavy wet diapers every 24 hours. If your baby’s output drops below this, contact your care team.
Managing Daily Doses and Spitting Up
Because you will be giving three medications daily for a year, your baby will inevitably spit up or vomit after a dose. Do not automatically give another dose. Guessing can lead to an accidental overdose or underdose. Contact your pharmacist or pediatrician immediately to ask if you should re-dose based on how much time passed between the medication and the spit-up.
Why Routine Blood Draws Are Essential
Because drops in blood counts and kidney stress are not always visible from the outside, your child will need frequent laboratory monitoring. This often means weekly or biweekly blood draws at the start of treatment, eventually spacing out as their body adjusts [4][5].
- Do not skip these appointments. They are the only reliable way to catch bone marrow suppression early, before your child gets sick.
- The lab results tell your doctor exactly how much folinic acid your baby needs to stay safe.
- Monitoring protocols will also check kidney function to detect any early signs of stress from the sulfadiazine [6].
Blood is typically drawn using small heel pricks or tiny venous draws. To make these visits easier, ensure your baby is well-fed and hydrated beforehand, which makes blood flow easier, and bring a pacifier or be ready to feed them immediately after for comfort.
Emergency Checklist
Go to the emergency room or call your doctor immediately if your baby experiences:
- Any fever
- A new, spreading skin rash, particularly with blisters, peeling, or mouth sores
- Unexplained bruising or pinpoint purple dots on the skin
- Extreme lethargy or difficulty waking up
- A significant drop in wet diapers (less than 6 in 24 hours)
Common questions in this guide
Why does my baby need routine blood draws while on pyrimethamine and sulfadiazine?
Can I use over-the-counter folic acid instead of folinic acid for my baby?
What should I do if my baby gets a fever while taking toxoplasmosis medication?
What should I do if my baby spits up their medication?
How can I protect my baby's kidneys while taking sulfadiazine?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is the exact schedule for my baby's blood draws over the next 12 months, and how quickly will we get the results each time?
- 2.What should I do if my baby spits up their medication right after I give it?
- 3.How will we adjust the folinic acid (leucovorin) dose if my baby's white blood cell count begins to drop?
- 4.Are there any specific diaper output targets I should monitor to ensure my baby stays hydrated enough to protect their kidneys?
- 5.Who should I contact after hours if my baby develops a new skin rash or fever over the weekend?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (14)
- 1
Atypical congenital toxoplasmosis presenting with neonatal jaundice and central nervous system involvement: a case report and therapeutic challenges to limited access to first-line anti-toxoplasma medications.
Wang L, Ding K, Yu S, et al.
Frontiers in pediatrics 2026; (14()):1874973 doi:10.3389/fped.2026.1874973.
PMID: 42427959 - 2
Sulfadiazine Hypersensitivity and Desensitization in Children With Congenital Toxoplasmosis: A Report on Two Cases.
Yamamoto K, Kutsuna S, Kato Y, et al.
The Pediatric infectious disease journal 2021; (40(4)):324-326 doi:10.1097/INF.0000000000002972.
PMID: 33181786 - 3
Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.
McLeod R, Boyer K, Karrison T, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006; (42(10)):1383-94 doi:10.1086/501360.
PMID: 16619149 - 4
High Frequency of Bone Marrow Depression During Congenital Toxoplasmosis Therapy in a Cohort of Children Identified by Neonatal Screening in Minas Gerais, Brazil.
Carellos EVM, de Andrade JQ, Romanelli RMC, et al.
The Pediatric infectious disease journal 2017; (36(12)):1169-1176 doi:10.1097/INF.0000000000001561.
PMID: 28151845 - 5
Adverse Event Profile of Pyrimethamine-Based Therapy in Toxoplasmosis: A Systematic Review.
Ben-Harari RR, Goodwin E, Casoy J
Drugs in R&D 2017; (17(4)):523-544 doi:10.1007/s40268-017-0206-8.
PMID: 28879584 - 6
Nephrolithiasis associated with sulfadiazine therapy in an infant with congenital toxoplasmosis: a case report.
Nie Y, Wen Y
BMC pediatrics 2026; (26(1)).
PMID: 41888722 - 7
Pediatric SJS-TEN: Where are we now?
Ramien M, Goldman JL
F1000Research 2020; (9()) doi:10.12688/f1000research.20419.1.
PMID: 32850118 - 8
Adverse Reactions in Antifolate-Treated Toxoplasmic Retinochoroiditis.
Borkowski PK, Brydak-Godowska J, Basiak W, et al.
Advances in experimental medicine and biology 2018; (1108()):37-48 doi:10.1007/5584_2018_262.
PMID: 30191431 - 9
Diagnosis of Congenital Toxoplasmosis: Challenges and Management Outcomes.
Losa A, Carvalho I, Sousa B, et al.
Cureus 2024; (16(1)):e52971 doi:10.7759/cureus.52971.
PMID: 38406029 - 10
Roth Spots in Ocular Toxoplasmosis.
Furtado JM, Toscano M, Castro V, Rodrigues MW
Ocular immunology and inflammation 2016; (24(5)):568-70 doi:10.3109/09273948.2015.1047035.
PMID: 26472315 - 11
A Retrospective Review of Silver Sulfadiazine Use in Patients With Sulfa-Allergic Burns at a Regional Burn Center.
West W, Buller KT, McArthur M, et al.
Cureus 2025; (17(5)):e84360 doi:10.7759/cureus.84360.
PMID: 40535410 - 12
A 10-year retrospective cohort study of the management of toxic epidermal necrolysis and Stevens-Johnson syndrome in a New South Wales state referral hospital from 2006 to 2016.
Chan L, Cook DK
International journal of dermatology 2019; (58(10)):1141-1147 doi:10.1111/ijd.14426.
PMID: 30908601 - 13
Evaluation of the patients diagnosed with Stevens Johnson syndrome and toxic epidermal necrolysis: a single center experience.
Çekiç Ş, Canıtez Y, Sapan N
Turk pediatri arsivi 2016; (51(3)):152-158 doi:10.5152/TurkPediatriArs.2016.3836.
PMID: 27738400 - 14
Drug-related Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review.
Arora R, Pande RK, Panwar S, Gupta V
Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine 2021; (25(5)):575-579 doi:10.5005/jp-journals-10071-23826.
PMID: 34177178
This page provides educational information about congenital toxoplasmosis treatments. Always consult your pediatrician before adjusting medication doses or managing suspected side effects.
Get notified when new evidence is published on Congenital toxoplasmosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.